Humana said on Thursday it would sell a 60% interest in the hospice and personal care divisions of its Kindred at Home unit for $2.8 billion to private investment firm Clayton, Dubilier & Rice, sending its shares up nearly 2% before the bell.
The U.S. health insurer took full ownership of home health care business Kindred at Home last year after acquiring the remaining 60% stake it did not own from TPG Capital for $5.7 billion to expand its patient care business.
Humana said it intends to use proceeds from the transaction for repayment of debt and share buybacks.
Get the week’s top news delivered directly to your inbox – Sign up for our newsletter
The company does not anticipate a material impact to 2022 earnings from this transaction, which is expected to close in the third quarter of 2022.
Once the deal closes, the hospice and personal care divisions will be restructured into a standalone operation with David Causby, the current president and CEO of these segments, leading the business.
Goldman Sachs & Co. LLC and Barclays are acting as financial advisers to Humana, while Deutsche Bank Securities Inc and UBS Investment Bank are acting as financial advisers to CD&R.
Source: Reuters
Can’t stop reading? Read more
KKR acquires Australia’s Zenith Energy in $1.1bn deal to target energy transition growth
KKR acquires Australia’s Zenith Energy in $1.1bn deal to target energy transition growth KKR has...
Harvard lab secures $39m private equity lifeline from İşbank arm to launch biotech venture
Harvard lab secures $39m private equity lifeline from İşbank arm to launch biotech venture İş...
Private credit boom lures ultra-wealthy as PE sentiment cools, says BlackRock
Private credit boom lures ultra-wealthy as PE sentiment cools, says BlackRock BlackRock reports...